ILVBL Antibody [Janelia Fluor® 585]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-78433JF585
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ICC/IF (Negative), Western Blot
Label
Janelia Fluor 585
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
A synthetic peptide made to an internal portion of the human ILVBL protein (between residues 350-500) [UniProt A1L0T0]
Localization
Membrane; Single-pass membrane protein.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for ILVBL Antibody [Janelia Fluor® 585]
Application
Recommended Usage
ICC/IF (Negative)
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ILVBL
Alternate Names
acetolactate synthase homolog, acetolactate synthase-like protein, AHASFLJ39061,209L8, EC 2.2.1, EC 2.2.1.-, ILV2H, ilvB (bacterial acetolactate synthase)-like, IlvB-like protein, MGC1269, MGC19535
Gene Symbol
ILVBL
Additional ILVBL Products
Product Documents for ILVBL Antibody [Janelia Fluor® 585]
Product Specific Notices for ILVBL Antibody [Janelia Fluor® 585]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...